I am a breastfeeding mother and i want to know if it is safe to use Gabapentinum [INN-Latin]? Is Gabapentinum [INN-Latin] safe for nursing mother and child? Does Gabapentinum [INN-Latin] extracts into breast milk? Does Gabapentinum [INN-Latin] has any long term or short term side effects on infants? Can Gabapentinum [INN-Latin] influence milk supply or can Gabapentinum [INN-Latin] decrease milk supply in lactating mothers?
- DrLact safety Score for Gabapentinum [INN-Latin] is 1 out of 8 which is considered Safe as per our analyses.
- A safety Score of 1 indicates that usage of Gabapentinum [INN-Latin] is mostly safe during lactation for breastfed baby.
- Our study of different scientific research also indicates that Gabapentinum [INN-Latin] does not cause any serious side effects in breastfeeding mothers.
- Most of scientific studies and research papers declaring usage of Gabapentinum [INN-Latin] safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Antiepileptic drug that is also used in the treatment of neuropathic pain and Restless Leg Syndrome. It is excreted into breast milk in clinically non-significant amount. No problem was observed in infants whose mothers were on this medication.Plasma levels in those infants were undetectable or very low.
Limited information indicates that maternal doses of Gabapentinum [INN-Latin] up to 2.1 grams daily produce relatively low levels in infant serum. Monitor the infant for drowsiness, adequate weight gain, and developmental milestones, especially in younger, exclusively breastfed infants and when using combinations of anticonvulsant or psychotropic drugs. A single oral dose of either 300 mg or 600 mg given to the mother before cesarean section appeared to have no effect on breastfeeding initiation.[1] An expert consensus guideline indicates that Gabapentinum [INN-Latin] is an acceptable choice for refractory restless leg syndrome during lactation.[2]
Three infants who were 2 to 3 weeks of age and one who was 14 weeks of age were breastfed during maternal use of Gabapentinum [INN-Latin] in an average daily dosages of 1575 mg (range 600 mg to 2.1 grams daily). One infant's mother was also taking topiramate and lorazepam and another infant's mother was taking clonazepam. No adverse effects were noted in any of the infants.[3] A follow-up publication by the same authors found no adverse reactions among 3 additional breastfed infants whose mothers were taking Gabapentinum [INN-Latin] during pregnancy and lactation.[4]< An exclusively breastfed 5-day-old infant whose mother was taking Gabapentinum [INN-Latin] 1.2 grams and levetiracetam 2.5 grams daily during pregnancy and lactation appeared healthy to the investigators throughout the 6- to 8-week study period.[6] An infant whose mother was taking Gabapentinum [INN-Latin] 36.7 mg/kg daily breastfed her infant 6 to 7 times daily for most of the first 1.6 months of life with some additional artificial feeding at night. The mother was also taking amitriptyline 2.5 mg daily. At 1.6 months of age, the infant was found to be healthy with a weight between the 10th and 25th percentiles, having been at the 50th percentile at birth. His age on the Denver developmental test was the same as his chronological age.[5]
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.